You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
You know the expression – “the more things change, the more they stay the same.” Well if there’s anything that we learned over the last year, it’s that this phrase absolutely does not apply to anything related to IVL.
Topics: Medical Meetings, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences
Following its presentation as a late-breaking clinical at TCT Connect and simultaneous publication in the Journal of the American College of Cardiology (JACC) we sat down with Dr. Jonathan Hill, Consultant Cardiologist at the Royal Brompton Hospital in London, to get his perspective on the results, how they build on CAD I & II outcomes, and where they fit into clinician’s daily decision-making process when treating calcified lesions. We hope you enjoy his perspective.
Topics: Coronary IVL, DISRUPT CAD, Coronary Clinical Data, Shockwave C2, Coronary Conferences
If Shockwave IVL had a personality, we’d like to think that we’d be a bit on the eccentric side. A little unconventional and taking a slightly different path than everyone else. After all, you won’t be successful in introducing a new disruptive technology if you’re marching to the same drumbeat as everyone else.
Topics: DISRUPT CAD, Coronary Cases, Shockwave C2, Coronary Conferences, CAD Applications - Eccentric Lesions
In case you weren’t able to make it to EuroPCR’s e-Course last week, you missed a great discussion among some of coronary IVL’s most knowledgeable operators about how they’re using the technology in the real-world setting. Lucky for you, we’ve included the sponsored roundtable discussion below featuring Drs. Benjamin Honton (FR), Javier Escaned (ES) and Michael Lee (HK). We hope you enjoy hearing their perspectives from across Europe and Asia.
Topics: Coronary IVL, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences, CAD Applications - Eccentric Lesions
Regardless of what party you align with or what type of calcium is the most challenging to you, CRT has a lithotripsy presentation for everyone this year in DC. Whether it’s calcified iliacs that prevent transfemoral access for TAVR and Impella procedures or calcified tibials in critical limb ischemia. Or if you’re in the EU (and the UK) and calcified bifurcations, ostials and left mains are more your cup of tea, we've got that too. Regardless of where challenging calcium presents itself, CRT will be showcasing how lithotripsy addresses it.
Topics: Coronary Conferences
The inaugural TopShock Symposium celebrating the one-year anniversary of coronary IVL at EuroPCR 2019 was a momentous occasion for everyone who participated, but none more so than for Dr. Alfonso Jurado-Román, the winner of the case competition.
Topics: Coronary Cases, Shockwave C2, Coronary Conferences
After being held in various cities over the recent years, TCT is back home where it belongs – back in the Bay, and joyfully, right in our backyard. We couldn’t be more excited about TCT this year. And no, it’s not just because those of us who live in the city are lucky enough to walk to work for a few beautiful September days.
Topics: Coronary Cases, Shockwave C2, Coronary Conferences
Novelist, poet, playwright, and art collector Gertrude Stein is famous for the quote, “America is my country and Paris is my hometown.” Well, that’s exactly how we felt this spring with the warm reception IVL received at EuroPCR 2019.
Topics: Coronary Cases, Shockwave C2, Coronary Conferences
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
